Conifer Point Pharmaceuticals is a pioneering startup in the biopharma, biotechnology, and pharmaceutical industries, founded in 2014. The company's mission is to revolutionize drug discovery by providing web-based, user-friendly drug design tools. Conifer Point has made significant scientific breakthroughs in fragment-based drug design, promising a transformation in drug discovery. Their prototype Cloud-hosted Web application for chemical modeling and drug discovery, including exclusive fragment-based design software, sets them apart in the market. The platform also incorporates industry standard methodologies such as energy minimization and docking. This first-in-class molecular design application is accessible via a browser, with fragment searches being run in the Cloud through Amazon Web Services. For more information and to access a free account, visit https://www.boltzmannmaps.com. With its innovative approach and potential to impact the pharmaceutical industry, Conifer Point Pharmaceuticals presents an exciting investment opportunity for venture capitalists.
There is no investment information
No recent news or press coverage available for Conifer Point Pharmaceuticals.
We care about your data, and we'd love to use cookies make your experience better.
